期刊名称：JOURNAL OF CANCER
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
ISSN: 1837-9664
Journal of Cancer is a peer-reviewed journal publishing papers of high quality in all areas of cancer related fields, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. Journal of Cancer is published in cooperation with American Registry of Pathology.
Now indexed in Science Citation Index (SCI) Expanded! Official impact factor expected in June 2014. Congratulations!
Indexed in PubMed and full texts in PubMed Central, Europe PubMed Central, and PMC Canada.
Rapid review and publication.
High visibility of articles over the Internet
About this journal
Journal of Cancer is a peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.
Types of articles:
- Research paper
- Short research communication
- Review
- Letter to the editor
Instructions to Authors
Instructions for Authors
Journal of Cancer welcomes submissions of research papers, reviews, mini-reviews and short research communications in all cancer-related areas. High quality reviews from leading researchers are particularly welcome and they will be processed in high priority. Case reports are no longer considered in this journal. Please do not submit case reports.
The Journal does not set specific length limit on research papers and reviews; however, authors are urged to be concise. Short research communication is limited to be under 2500 words. Authors can choose any preferred style and format for submission. For regular research papers, the Journal recommends that they are organized as Abstract, Introduction, Materials and Methods, Results, and Discussions, followed by Acknowledgements, Conflict of Interest, and References.
Review/Decisions
Manuscripts that are judged to be of insufficient quality or unlikely to be competitive enough for publication will be returned to the authors at the initial stage. The remaining manuscripts go through a review process, and possible decisions are: accept as is, minor revision, major revision, or reject. Authors should submit back their revisions within 1 month in the case of minor revision, or 3 months in the case of major revision. To submit a revision please sign in here and use the submit button at the right side of page. Manuscripts with significant results are typically reviewed and published at the highest priority.
Submission
Please embed figures and tables in the manuscript to become one single file for submission. Details for submission can be found in the submission page.
Publication Charges
Published articles of Journal of Cancer are open access and full texts appear in PubMed Central. This effectively removes the barriers for timely distribution of the articles and ensures that they can be read by as many as possible. The amount of fee charged by the journal is lower than many other PubMed Central journals (comparing to the fees charged by BioMedCentral and PLOS). Payment can be made by credit card, bank transfer, money order or check. Instruction for payment is sent during publication process and is also available in the manuscript login page as soon as manuscript is accepted. Publication fee is required to cover the cost of publication. Fee waiver is not available.
The Journal charges the following publication fee if and when the manuscript is accepted for publication:
Research paper/
Review/
Short research communication/
Others |
$AUD 1100 |
| Letter |
$AUD 650 |
* $AUD: Australian dollar
Reprints
Reprints can be ordered after copyediting and publication (in manuscript login page). Reprints are now printed on glossy paper with cover page. They are made of highest quality suitable for scientific corresponding.
Upon acceptance of the manuscript, please provide a final version (in Microsoft Word file) for copyediting purpose. Note that the final manuscript must be provided in Microsoft Word, and we cannot accept Latex and Tex files.
Please include figures at the end of manuscript Word file, or provide a high quality PDF containing all figures. Make sure images are of highest resolution, and any letters inside are clear and legible. If the figures or tables are created using PowerPoint, Photoshop, Microsoft Excel etc, please also provide the original files from those programs.
Title Page
The first letter of each word in title should use upper case. Include in the first page the article title, author's names, affiliations, corresponding author's phone/fax number and/or email. Abstract should not contain citations to references. Also provide 5-6 keywords.
Author's names: please provide full names. Important! Please write first name and middle name before surname or lastname, e.g., "Mike Johnson" (not "Johnson, Mike"; not "Johnson M."; not "M. Johnson").
Text
Please do not add number before subtitles.
Citation of Tables and Figures
Tables and Figures should be numbered consecutively. Citation of tables and figures should use the format: Table 1, Table 2, ... Figure 1, Figure 2, ... (or Fig. 1, Fig. 2, ...). Parts in a figure can be identified by A, B, C, D, ... . and cited as Fig. 2A, Fig. 2B, Fig. 2C. The abbreviation of "Table" to "Tab." for example "Tab. 1" should be avoided.
Math Formulas and Symbols
Simple mathematical formulas should be constructed using superscript, subscript, italic, and symbols in the Microsoft Word.
- Use symbols in the Fonts: (normal text) or Symbol fonts. To insert a symbol, use Insert/symbol in the Word menu.
- Use / for "divide" or "over". For example, 1/7, 5/(4+6).
- Use Symbol fonts for "±"; "≤" and "≥" (avoid underline).
Please avoid using math equations in Word whenever possible, as they have to be replaced by images in xml full text.
References
References should be numbered consecutively and cited in the manuscript text by number (not author and date). References should not be formatted as footnotes. Avoid putting personal communications, unpublished observations, conference abstracts or conference papers as references. A reference style for EndNote may be found here.
- Journal Paper
Please use the PubMed format. The sequence is as: [Author surname] [Author initials], [Other author surnames & initials]. [Article title]. [Journal name abbreviation]. [Year]; [Volume]: [First page number]-[Last page number].
- Journal paper must have journal name (or journal abbreviation), year, volume and page numbers. Please make sure that the year of publication is not missing.
- Please use ":" to separate volume and first page number.
- It is not necessary to highlight or italicize the title, journal name, or any part of references. Omit any "." in the journal abbreviations.
Examples:
- 1. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347: 2010-9.
- Supplement example:
2. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996; 22 (Suppl 4):S474-S481.
- No author given example:
3. [No authors listed]. Medicare program; criteria for Medicare coverage of adult liver transplants-HCFA. Final notice. Fed Regist. 1991; 56(71):15006-15018.
- In press example:
4. Cheung TMT, et al. Effectiveness of non-invasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest; in press.
- Epub ahead of print example:
5. Li W, Chen Y, Cameron DJ, et al. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Vision Res 2007; [Epub ahead of print].
- Book
- Kiloh LG, Smith JS, Johnson GF, et al. Physical treatment in psychiatry. Boston, USA: Blackwell Scientific Publisher; 1988.
- Chapters in Edited Book
- Beckenbough RD, Linscheid RL. Arthroplasty in the hand and wrist. In: Green DP, ed. Operative Hand Surgery, 2nd ed. New York: Churchill Livingstone; 1988: 167-214.
- Web Site
- [Internet] WHO: Geneva, Switzerland. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Revised 26 September 2003. http://www.who.int/csr/sars/country/table2003_09_23/en/
- [Internet] Kornberg R. http://nobelprize.org/nobel_prizes/chemistry/laureates/2006/press.html
Abbreviations
Abbreviations should be presented in one paragraph, in the format: "term: definition". Please separate the items by ";".
E.g. HIV: human immunodeficiency virus; SIV: simian immunodeficiency virus; ....
Ethics Committee Approval and Patient Consent
Experimental research involving human or animals should have been approved by author's institutional review board or ethics committee. This information can be mentioned in the manuscript including the name of the board/committee that gave the approval. Investigations involving humans will have been performed in accordance with the principles of Declaration of Helsinki. And the use of animals in experiments will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education by the New York Academy of Sciences, Ad Hoc Animal Research Committee.
If the manuscript contains photos or parts of photos of patients, informed consent from each patient should be obtained. Patient's identities and privacy should be carefully protected in the manuscript.
Competing Interests
Competing interests that might interfere with the objective presentation of the research findings contained in the manuscript should be declared in a paragraph heading "Competing interests" (after Acknowledgment section and before References). Examples of competing interests are ownership of stock in a company, grants, board membership, etc. If there is no competing interest, please use the statement "The authors have declared that no competing interest exists".
Author Biography
Authors now have the option to publish a biography together with the paper, with information such as MD/PhD degree, past and present positions, research interests, awards, etc. This increases the profile of the authors and is well received by international readers. Author biography can be added to the end of paper, in a section heading "Author biography". See samples of author biography, Sample A or Sample B.
For general information about preparing biomedical manuscripts, please consult the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication", available from http://www.icmje.org/.
Editorial Board
Editors-in-chief
Yan-Gao Man, MD., PhD.
Vice president for Research and Collaboration
South Hospital of Nanjing
Nanjing, China
Naoto T. Ueno, MD., PhD.
Professor of Medicine
Chief of the Translational Breast Cancer Research Section, Department of Breast Medical Oncology
Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic
The University of Texas MD Anderson Cancer Center
Houston, Texas, USA
Editors-in-Chief Profile
Dr. Yan-Gao Man received his medical and MS degrees from the Hubei Medical College of China, and PhD in Cell Biology/Anatomy in 1998 from Howard University Medical School, Washington DC. He completed postdoctoral training in Cancer Biology in 1999 at the National Cancer Institute, NIH, Bethesda, MD, USA. He served as the Director of the Gynecological and Breast Research Laboratory, Armed Forces Institute of Pathology and American Registry of Pathology, from 1995 to 2011, and as a Senior Scientist and Senior Distinguished Scientist at the Diagnostic and Translational Research Center, Henry Jackson Foundation, from 2011 to 2013. Currently, he serves as the Director of the Research Laboratory and International Collaboration, Bon Secours Cancer Institute, Bon Secours Health System, Richmond, VA, an Adjunct Senior Scientist, at Hackensack University Medical Center, Hackensack, NJ, USA, and as a Vice President for Research and Collaboration, at the South Hospital of Nanjing, Nanjing, China. He is also a Visiting Professor of the Jilin University, China, an Associate Editor-In-Chief of Cancer Epidemiology, an Editorial Board Member of The Open Breast Cancer Journal, and a grant review panel member for a number of international and national cancer-research organizations.
Dr. Man has authored and co-authored over 180 published scientific papers and abstracts, 46 non-scientific articles, 4 book chapters, and 14 novel protocols for molecular and immunohistochemical assays. He was the recipient and co-recipient of 18 funded research grants and inventor and co-inventor of 3 patents. Currently, Dr. Man’s research interests focus primarily on the mechanism of tumor invasion and metastasis. He is the originator of novel hypotheses for both tumor invasion and metastasis. His hypotheses have increasingly gained recognition, and he has been invited by colleagues in the National Institutes of Health, Dana-Farber Cancer Institute of Harvard Medical School, Johns Hopkins University, UCLA, Barbara Ann Karmanos Cancer Institute, Florida State University, and a number of other international prestigious Institutions to present his hypotheses. His hypothesis of tumor invasion has been recognized as more compatible with existing experimental evidence than the traditional “protoelytic enzyme” theory [Pandey PR et al. Front Biosci. 15: 226–236, 2011].
Dr. Man's contact information is as follows:
Dr. Yan-Gao Man, Bon Secours Cancer Institute, 5855 Bremo Road, Richmond, VA 23226. Phone: 301-326-6731; Fax: 301-879-0816. Email: yman@jcancer.org
Updated on Sept 10, 2013
Dr. Naoto T. Ueno gained his medical degree in 1989 from Wakayama Medical College, Wakayama, Japan, and PhD in Cancer Biology from The University of Texas Graduate School of Biomedical Sciences, Houston, TX, in 1999. He is currently full professor and Chief of the Translational Breast Cancer Research Section of Department of Breast Medical Oncology, and Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center. He also serves as the Committee Chair of Solid Tumor Committee of Center for International Blood & Marrow Transplant Research (CIBMTR), Milwaukee, WI. Dr. Ueno is on Board of Directors for Japan Comprehensive Cancer Network, Breast (Tokyo, Japan), Chair of Sister Institution between Tokyo Oncology Consortium and MD Anderson Cancer Center, and Chair of MD Anderson Cancer Center Breast Cancer Bone Metastasis Working Group. Dr. Ueno was Chair of The European Group for Blood & Marrow Transplantation, 2nd International Meeting of Allogeneic Transplantation for Solid Tumor, Milan, Italy, 2005, and Chair of The European Group for Blood & Marrow Transplantation, 3rd International Meeting of Allogeneic Transplantation for Solid Tumor, Siena, Italy, 2008. Dr. Ueno's primary research interest is dissecting the molecular events related to cytotoxicity induced by chemotherapy or targeted therapy for breast cancer and ovarian cancer. His research is well funded by NIH and Susan G. Komen Breast Cancer Foundation. Dr. Ueno is author or co-author of more than 120 articles in peer-reviewed journals, 17 book chapters, and 46 abstracts.
Dr. Ueno's contact information is as follows:
Naoto T. Ueno, M.D., Ph.D., F.A.C.P., The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX 77030, USA. Phone: 713-792-8754; Fax: 713-794-4385. Email: nueno@jcancer.org
Updated on March 5, 2013
Editors and editorial members
Myron Arlen, MD
Chief of Division of Surgical Oncology North Shore University Hospital
Manhasset, New York, USA
Chairman of the Board
Neogenix Oncology Inc.
Great Neck, New York, USA
Itzhak Avital, MD
Medical Director of Bon Secours National Cancer Institute (BSNCI)
Richmond, VA, USA
Suni Badve, MD, FRCPath
Professor
Department of Pathology and Laboratory Medicine
Indiana University-Purdue University
Indianapolis, IN, USA
Gennady Bratslavsky, MD
Professor and Chairman
Urology Department
SUNY Upstate Medical University
Syracuse, NY, USA
Karl-Friedrich Becker, MD
Professor
Institut für Pathologie
Technische Universität München
München, Germany
Patricia Berg, PhD.
Professor
Breast Cancer Research Laboratory
Department of Molecular Biology and Biochemistry
George Washington University
Washington DC, USA
Carlos Cordon-Cardo, MD., PhD.
Professor and Vice-Chair, Department of Pathology
Professor and Member, Department of Urology
Associate Director, Herbert Irving Comprehensive Cancer Center
Columbia University
New York, NY, USA
Marco Bregni, MD
Professor
Unit of Medical Oncology
Ospedale San Giuseppe
Via San Vittore, 12
20123 Milano, Italy
Darryl Carter, MD
Consulting pathologist
The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Luciane R. Cavalli, PhD.
Assistant Professor (tenured tracked) of Oncology
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington DC, USA
Liang Cheng, MD.
Professor of Pathology and Urology
Director of Molecular Diagnostics Service and Molecular Pathology
Laboratory Chief of Genitourinary Pathology Division
Indiana University School of Medicine
Indianapolis, IN, USA
William CS Cho, PhD
Professor and Scientific Officer
Queen Elizabeth Hospital
Department of Clinical Oncology,
Hong Kong, China
Gabriela Dontu, MD., PhD
Clinical Reader in Mammary Stem Cell Biology
Department of Research Oncology
King's College London School of Medicine
Guy's Hospital
Great Maze Pond London SE19RT, UK
Shaheenah Dawood, MD.
Department of Medical Oncology
Dubai Hospital
Dubai, United Arab Emirates
Antonio Tito Fojo, MD., PhD.
Head, Experimental Therapeutics Section
National Cancer Institute/NIH
Bethesda, MD, USA
Sidney W. Fu, MD., PhD.
Professor
Associate Director, Division of Genomic Medicine
Department of Medicine, and of Microbiology, Immunology & Tropical Medicine
George Washington University Medical Center
Washington DC, USA
Yasuhiro Fujiwara, MD.
Breast and Medical Oncology Division
Department of Medical Oncology
National Cancer Center Hospital
Tokyo, Japan
Alfredo Fusco, MD., PhD
Professor
Director, Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio
Nazionale delle Ricerche
Naples, Italy
Renata B. Greenspan, MD
Director, BioSpecimen Network
Associate Director, U.S. Military Cancer Institute
Walter Reed Army Medical Center
Bethesda, MD, USA.
Michael Grinkemeyer, MC, USAF, Colonel
Air Force Research Labs (AFRL)
Ohio, USA
Michael Gnant, MD., PhD.
Professor
Director, Department of Surgery
Medical University of Vienna
Vienna, Austria
Russell A. Harley, MD
Chairman
Department of Pulmonary and Mediastinal Pathology
The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Mitchell Ho, PhD.
Head, Antibody Therapy Unit
Laboratory of Molecular Biology
National Cancer Institute, NIH
Bethesda, MD, USA
Yi-Hsuan Hsiao, MD., PhD.
Permanent attending physician
Department of Obstetrics and Gynecology
Changhua Christian Hospital
Changhua, Taiwan
Chiyo K. Imamura, PhD., BCOP
Department of Clinical Pharmacokinetics and Pharmacodynamics
School of Medicine, Keio University
2N9 Institute of Integrated Medical Research
35 Shinanomachi, Shinjuku-ku
Tokyo, Japan
Bin Jiang, MD., PhD.
Colorectal Branch directors of National Chinese Medicine Society for Clinical Education and Research
Tumor Biomarker Committee Member of Jiangsu Province Anti-Cancer Association
Tumor Specialty Committee Member of Jiangsu Province Integrative Medicine Association
Associate Director, National Medical Centre of Colorectal Diseases
Associate professor, University of Traditional Chinese Medicine (TCM)
The Third Affiliated Hospital of Nanjing University of T.C.M
Nanjing, China
Anahid Jewett, PhD, MPH
Professor and Director of Tumor Immunology Laboratory
Division of Oral Biology and Medicine
The Jane and Jerry Weintraub Center for Reconstructive Biotechnology
Jonsson Comprehensive Cancer Center
UCLA School of Dentistry and Medicine
Los Angeles, CA, USA
Dexin Kong, PhD.
Professor
School of Pharmaceutical Sciences,
Research Center of Basic Medical Sciences,
Tianjin Medical University
Tianjin, China
Julie E. Lang, MD, FACS
Associate Professor
Norris Comprehensive Cancer Center
University of Southern California,
Los Angeles, CA, USA
Jerzy Lasota, MD., PhD
Laboratory of Pathology
National Cancer Institute
Bethesda, MD, USA
AiJun Liu, MD., PhD.
Department of Pathology
Beijing 301 Hospital
Beijing, China
Mofang Liu, PhD
Associate professor and principal investigator
Institute of Biochemistry and Cell Biology
Shanghai Institutes of Biological Sciences
Chinese Academy of Sciences
Shanghai, China
Yi Lu, PhD.
Professor
Director of the Urological Cancer Division
University of Tennessee Center for Cancer Research
College of Medicine
University of Tennessee Health Science Center
Memphis, TN, USA
George P. Lupton, MD.
Chairman
Department of Dermatopathology
The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Jeffrey T. Mason, PhD.
Program Director
Veterans Affairs Medical Center
Washington DC, USA
Maria J Merino, MD
Chief, Translational Surgical Pathology
National Cancer Institute
National Institutes of Health
Bethesda, MD, USA
Markku Miettinen, MD.
Head of surgical Pathology
Laboratory of Pathology
National Cancer Institute
Bethesda, MD, USA.
Florabel G. Mullick, MD., ScD, FCAP
Formal Director of Armed Forces Institute of Pathology (AFIP)
Consultant, The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Seigo Nakamura, MD, PhD
Professor of Surgery, Showa University School of Medicine
Director of Breast Center, Showa University Hospital
Tokyo 142-8666, Japan
Ramesh K. Nayak, PhD
Scientific Review Officer
Center for Peer Review and Scientific Management
Health and Civil Services Sector
SRA International, Inc.
Frederick, MD, USA
Herbert Nieburgs, MD
Founding Editor-in-chief, Cancer Detection and Prevention
Professor, University of Massachusetts Medical School
Worcester, MA, USA
Timothy O’Leary, MD., PhD.
Director of Clinical Scientific Research and Development
US Department of Veterans Affairs
Washington DC, USA
Annika Lindblom, MD
Professor
Department of Molecular Medicine and Surgery
Karolinska Institute
Stockholm, Sweden
Yoshihiro Moriya, MD.
Head, Colorectal Division
Department of Surgery
National Cancer Center Hospital
Tokyo, Japan
Zhou Luo Ou, PhD.
Professor and principal investigator
Cancer Hospital, Fudan University
Shanghai, China
Francesco Perrone, MD.
Director Clinical Trials Unit
National Cancer Institute
Naples, Italy
Qing-Xiang Amy Sang, PhD.
Professor
Department of Chemistry and Biochemistry Chemical Sciences Laboratory Bldg.
Florida State University
Tallahassee, FL, U.S.A
Shijie Sheng, PhD.
Professor
Co-Leader of the Proteases and Cancer Program
The Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, MI, USA
Isabell A. Sesterhenn, MD
Chairman
Department of Genitourinary Pathology
The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Arun Seth, PhD.
Director, Molecular Diagnostics, Anatomic Pathology, Sunnybrook Health Sciences Center
Senior Scientist, Molecular and Cellular Biology
Academic Director, Center for Genomic Studies Sunnybrook Research Institute
Professor, Department of Laboratory Medicine and Pathobiology Faculty of Medicine University of Toronto
Toronto, Canada
Shiv Srivastava, PhD
Professor and Scientific Director
Center for Prostate Cancer Research
Uniformed Service University and Henry M. Jackson Foundation
Rockville, MD, USA
Yan A. Su, MD, PhD
Senior Investigator, Gene and Protein Biomarkers
President and CEO, GenProMarkers Inc.
Rockville, MD, USA
Alexander Stojadinovic, MD, FACS; COL USA MC
COL US Army Medical Corps
GI Cancer Program Leader, United States Military Cancer Institute
Professor of Surgery, Uniformed Services University
Professor of Medicine, Uniformed Services University
Director, Combat Wound Initiative Program (www.cwiprogram.org)
Medical Director, Complex Wound and Limb Salvage Center
Walter Reed Army Medical Center; Uniformed Services University of the Health Sciences
Bethesda, MD, USA.
Peter M Schlag, MD., PhD
Professor
Charité Comprehensive Cancer Center
Charité – Universitätsmedizin Berlin
Berlin, Germany
Edward A. Stadtmauer, MD., PhD.
Professor
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA, USA
Toru Sugiyama, MD.
Iwate Medical University School of Medicine
Morioka Iwate, Japan
Jie Tang, MD
Director
Department of Ultrasound Division
Chinese PLA General Hospital
Beijing, China
Guanghua Wang, MD
Chief of Molecular Pathology
The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Xue-Ping Wang, MD
Director of Cellular and Molecular Biology-Great Neck
Neogenix Oncology Inc
Great Neck, New York, USA
Lixin Wei, MD
Professor
Director of Department of Pathology
Chinese PLA General Hospital
Beijing, China
Tongli Xia, MD
Advisor expert and Professor, Institute of Urology, the first Hospital, Peking University
Director, The consultant center of pathology, Wu Jieping Medical Foundation
Beijing, China
Xiaoming Xie, MD.
Professor and Chairman of Department of Breast Oncology
Director of Laboratory of Cancer Biotechnology
State Key Laboratory of Oncology in Southern China Sun Yat-Sen University Cancer Center
Beijing, China
Zhi Min Yuan, MD., PhD
Professor and Chief
Division of Radiation Biology
Department of Radiation Oncology
UT Health Science Center
San Antonio, TX, USA
Shimin Zhang, MD., PhD.
Chief of FISH Laboratory
The Joint Pathology Center (JPC)
606 Stephen Sitter Ave.
Silver Spring, MD, USA
Ying Zhang, MD, PhD
Professor
Department of Molecular Microbiology and Immunology
Bloomberg School of Public Health
Johns Hopkins University
Baltimore, MD, USA
Chengquan Zhao, MD.
Associated Professor
Department of Pathology
Magee-Womens Hospital
University of Pittsburgh School of Medicine
Pittsburgh, PA, USA
|
